Marc Ferrante

Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven

Affiliated withKU Leuven University Hospitals Leuven, KU Leuven

Research Area

Biography

Marc Ferrante has not added Biography.
If you are Marc Ferrante and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2022

Other Publications

Article	Year
Second primary malignancies in patients with a gastrointestinal neuroendocrine tumour: a case report and review of the literature. Acta gastro-enterologica Belgica\| PubMed ID: 21086947	2010
Medical therapy and mucosal healing. Current drug targets\| PubMed ID: 22664087	2012
Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab. Immunology\| PubMed ID: 23039249	2013
Certolizumab pegol in the treatment of Crohn's disease. Expert opinion on biological therapy\| PubMed ID: 23451881	2013
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflammatory bowel diseases\| PubMed ID: 23518809	2013
Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease. PloS one\| PubMed ID: 23894361	2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Gastroenterology\| PubMed ID: 23954314	2013
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut\| PubMed ID: 24021287	2014
Drug safety evaluation of certolizumab pegol. Expert opinion on drug safety\| PubMed ID: 24156537	2014
Targeting TNF-α for the treatment of inflammatory bowel disease. Expert opinion on biological therapy\| PubMed ID: 24206084	2014
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis. Inflammatory bowel diseases\| PubMed ID: 24871805	2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 25117777	2015
Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis. PloS one\| PubMed ID: 25546151	2014
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. Gastroenterology\| PubMed ID: 25724455	2015
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial. Gut\| PubMed ID: 25862647	2016
Immunogenicity to infliximab is associated with HLA-DRB1. Gut\| PubMed ID: 25876612	2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence. Journal of Crohn's & colitis\| PubMed ID: 25926532	2015
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. Journal of Crohn's & colitis\| PubMed ID: 26116558	2015
Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy. Inflammatory bowel diseases\| PubMed ID: 26308438	2015
Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease. Inflammatory bowel diseases\| PubMed ID: 26313692	2015
Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease. Journal of Crohn's & colitis\| PubMed ID: 26351381	2015
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease. Journal of Crohn's & colitis\| PubMed ID: 26351386	2015
Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases. Inflammatory bowel diseases\| PubMed ID: 26383913	2015
Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut\| PubMed ID: 26423113	2017
rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. American journal of respiratory and critical care medicine\| PubMed ID: 26509335	2016
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. Journal of Crohn's & colitis\| PubMed ID: 26519463	2016
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 26681486	2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis. Journal of Crohn's & colitis\| PubMed ID: 26738756	2016
Identifying predictors of low adherence in patients with inflammatory bowel disease. European journal of gastroenterology & hepatology\| PubMed ID: 26760588	2016
Letter: smoking as a modifiable risk factor for a complicated course in Crohn's disease. Authors' reply. Alimentary pharmacology & therapeutics\| PubMed ID: 26782115	2016
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab. Journal of Crohn's & colitis\| PubMed ID: 27022161	2016
Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis. Journal of Crohn's & colitis\| PubMed ID: 27194531	2016
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut\| PubMed ID: 27207975	2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis. Journal of Crohn's & colitis\| PubMed ID: 27402915	2017
Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospe... Journal of Crohn's & colitis\| PubMed ID: 27466173	2017
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet (London, England)\| PubMed ID: 27477896	2016
A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease. The American journal of gastroenterology\| PubMed ID: 27481307	2016
A Simplified Geboes Score for Ulcerative Colitis. Journal of Crohn's & colitis\| PubMed ID: 27571771	2017
Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? Journal of Crohn's & colitis\| PubMed ID: 27591675	2017
Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment. European journal of gastroenterology & hepatology\| PubMed ID: 27603297	2017
Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC. Gut\| PubMed ID: 27802155	2018
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Expert opinion on biological therapy\| PubMed ID: 27817215	2017
Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab. The AAPS journal\| PubMed ID: 27873119	2017
Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis ... European journal of gastroenterology & hepatology\| PubMed ID: 27902515	2017
Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases\| PubMed ID: 28079621	2017
Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered care. European journal of gastroenterology & hepatology\| PubMed ID: 28118176	2017
Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease? Gut\| PubMed ID: 28159838	2017
Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability. Development (Cambridge, England)\| PubMed ID: 28442471	2017
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial. Gut\| PubMed ID: 28450388	2018
Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease. Nature communications\| PubMed ID: 28561062	2017
A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases. Expert opinion on drug safety\| PubMed ID: 28573876	2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study. Inflammatory bowel diseases\| PubMed ID: 28590343	2017
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease. Scandinavian journal of gastroenterology\| PubMed ID: 28622097	2017
Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window. Inflammatory bowel diseases\| PubMed ID: 28816757	2017
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease. Inflammatory bowel diseases\| PubMed ID: 28885228	2017
Management of Postoperative Crohn's Disease: Missing Pieces of the Puzzle. Journal of Crohn's & colitis\| PubMed ID: 28961940	2017
Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model. Journal of Crohn's & colitis\| PubMed ID: 28981768	2018
Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy. Journal of Crohn's & colitis\| PubMed ID: 28981886	2017
Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease. Journal of Crohn's & colitis\| PubMed ID: 29029005	2018
The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study. Annals of gastroenterology\| PubMed ID: 29118560	2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time. Inflammatory bowel diseases\| PubMed ID: 29140943	2017
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 29203225	2018
Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease. Journal of Crohn's & colitis\| PubMed ID: 29220430	2018
Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology. United European gastroenterology journal\| PubMed ID: 29238585	2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology\| PubMed ID: 29277560	2018
The operative risk and natural history after the diagnosis of ileal penetrating Crohn's disease. European journal of gastroenterology & hepatology\| PubMed ID: 29462028	2018
Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study. Inflammatory bowel diseases\| PubMed ID: 29668947	2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 29704680	2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists. United European gastroenterology journal\| PubMed ID: 29774158	2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. Inflammatory bowel diseases\| PubMed ID: 29788318	2018
Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort. Inflammatory bowel diseases\| PubMed ID: 29920582	2019
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients? Gut\| PubMed ID: 30007919	2019
Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase Studies. Journal of Crohn's & colitis\| PubMed ID: 30010739	2018
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing. Alimentary pharmacology & therapeutics\| PubMed ID: 30109889	2018
Edematous Colitis of an Unknown Cause, Diagnosis by Pattern Recognition. Gastroenterology\| PubMed ID: 30205100	2019
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease. Journal of Crohn's & colitis\| PubMed ID: 30239644	2018
When IBD is not IBD. Scandinavian journal of gastroenterology\| PubMed ID: 30256685	2018
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. Journal of Crohn's & colitis\| PubMed ID: 30281093	2019
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 30291910	2019
Vedolizumab in Refractory Microscopic Colitis: An International Case Series. Journal of Crohn's & colitis\| PubMed ID: 30329034	2019
Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry. Endoscopy\| PubMed ID: 30360011	2019
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information. The AAPS journal\| PubMed ID: 30564993	2018
Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients. Journal of gastroenterology and hepatology\| PubMed ID: 30589948	2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease. Frontiers in immunology\| PubMed ID: 30619339	2018
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease. Therapeutic drug monitoring\| PubMed ID: 30633088	2019
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition\| PubMed ID: 30633108	2019
Optimising infliximab induction dosing for patients with ulcerative colitis. British journal of clinical pharmacology\| PubMed ID: 30634202	2019
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial. Endoscopy\| PubMed ID: 30646403	2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease. Journal of Crohn's & colitis\| PubMed ID: 30657881	2019
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease. Alimentary pharmacology & therapeutics\| PubMed ID: 30663072	2019
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease. EBioMedicine\| PubMed ID: 30685385	2019
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates. Journal of Crohn's & colitis\| PubMed ID: 30715258	2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study. Journal of Crohn's & colitis\| PubMed ID: 30820530	2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. European journal of gastroenterology & hepatology\| PubMed ID: 30839436	2019
Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis. Journal of Crohn's & colitis\| PubMed ID: 30919886	2019
Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' reply. Alimentary pharmacology & therapeutics\| PubMed ID: 30920040	2019
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel disease. Scandinavian journal of gastroenterology\| PubMed ID: 31106617	2019
Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13. Scientific reports\| PubMed ID: 31296924	2019
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nature cell biology\| PubMed ID: 31371824	2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. Inflammatory bowel diseases\| PubMed ID: 31400283	2020
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 31446181	2020
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients. Journal of Crohn's & colitis\| PubMed ID: 31504343	2020
The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor. Journal of Crohn's & colitis\| PubMed ID: 31628842	2020
Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver\| PubMed ID: 31640916	2020
Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials. Frontiers in medicine\| PubMed ID: 31681784	2019
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience. United European gastroenterology journal\| PubMed ID: 31700634	2019
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients. Journal of clinical gastroenterology\| PubMed ID: 31789759	2020
Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases. Journal of Crohn's & colitis\| PubMed ID: 31875891	2020
Efficacy of JAK inhibitors in Ulcerative Colitis. Journal of Crohn's & colitis\| PubMed ID: 31879750	2020
Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density. Gut\| PubMed ID: 31915237	2020
Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations. Journal of pharmaceutical and biomedical analysis\| PubMed ID: 32151929	2020
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer? Alimentary pharmacology & therapeutics\| PubMed ID: 32162373	2020
Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remissio... Scandinavian journal of gastroenterology\| PubMed ID: 32180470	2020
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 32272248	2021
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey. European journal of gastroenterology & hepatology\| PubMed ID: 32282539	2020
Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota Recolonisation. Journal of Crohn's & colitis\| PubMed ID: 32333762	2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey. European journal of gastroenterology & hepatology\| PubMed ID: 32453008	2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? Frontiers in pharmacology\| PubMed ID: 32457619	2020
High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 32461138	2021
Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis. Gastroenterology\| PubMed ID: 32474118	2020
Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation. Journal of Crohn's & colitis\| PubMed ID: 32556102	2020
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells. Immunity, inflammation and disease\| PubMed ID: 32567222	2020
Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort. United European gastroenterology journal\| PubMed ID: 32631177	2020
2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmunity reviews\| PubMed ID: 32663621	2020
Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis. Cells\| PubMed ID: 32731480	2020
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis. The European respiratory journal\| PubMed ID: 32747394	2021
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial. The American journal of gastroenterology\| PubMed ID: 32759621	2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label. European journal of gastroenterology & hepatology\| PubMed ID: 32804854	2021
Ulcerative colitis. Nature reviews. Disease primers\| PubMed ID: 32913180	2020
Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon. Journal of Crohn's & colitis\| PubMed ID: 32915959	2021
Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn's disease. Gut\| PubMed ID: 32928916	2021
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium. Frontiers in immunology\| PubMed ID: 32983101	2020
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating form. Scandinavian journal of gastroenterology\| PubMed ID: 33135491	2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations. Journal of Crohn's & colitis\| PubMed ID: 33245363	2021
Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis. Inflammatory bowel diseases\| PubMed ID: 33313682	2021
Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD. Journal of Crohn's & colitis\| PubMed ID: 33341879	2021
Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resection. International journal of colorectal disease\| PubMed ID: 33479821	2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases. British journal of clinical pharmacology\| PubMed ID: 33604964	2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus. Frontiers in pediatrics\| PubMed ID: 33614555	2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease. Inflammatory bowel diseases\| PubMed ID: 33624092	2021
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways. Frontiers in immunology\| PubMed ID: 33790898	2021
Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis. Thorax\| PubMed ID: 33859053	2021
Current Use of Fecal Calprotectin in the Management of Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology\| PubMed ID: 34035707	2020
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study. Journal of Crohn's & colitis\| PubMed ID: 34077509	2021
Chronic Antibiotic-Refractory Pouchitis: Management Challenges. Clinical and experimental gastroenterology\| PubMed ID: 34163205	2021
Population pharmacokinetic-pharmacodynamic model-based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease. British journal of clinical pharmacology\| PubMed ID: 34197653	2022
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy. The Journal of pediatrics\| PubMed ID: 34481805	2022
Inflammatory Bowel Disease-related Behaviours [IBD-Bx] Questionnaire: Development, Validation and Prospective Associations with Fatigue. Journal of Crohn's & colitis\| PubMed ID: 34622275	2022
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease. Journal of Crohn's & colitis\| PubMed ID: 34664635	2022
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study. United European gastroenterology journal\| PubMed ID: 34694746	2021
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD. Inflammatory bowel diseases\| PubMed ID: 34751766	2021
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. The lancet. Gastroenterology & hepatology\| PubMed ID: 35026171	2022
Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases. Expert review of clinical pharmacology\| PubMed ID: 35034509	2021
Introduction of subcutaneous infliximab CT-P13 and vedolizumab in clinical practice: a multi-stakeholder position statement highlighting the need for post-marketing studies. Journal of Crohn's & colitis\| PubMed ID: 35078228	2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial. Inflammatory bowel diseases\| PubMed ID: 35099555	2022
Severe Necrotizing Colitis in a 45-Year-Old Woman Without a Cardiovascular History. Gastroenterology\| PubMed ID: 35149030	2022
Postoperative Crohn's Disease Recurrence: Time to Adapt Endoscopic Recurrence Scores to the Leading Surgical Techniques. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 35183769	2022
Proctocolectomy and ileal pouch-anal anastomosis for the treatment of collagenous colitis. Clinical journal of gastroenterology\| PubMed ID: 35220554	2022
Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication? Inflammatory intestinal diseases\| PubMed ID: 35224012	2022
In Memoriam: Emeritus Prof. Dr. Paul Rutgeerts (1948-2020). Gastroenterology\| PubMed ID: 35259344	2022
Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study... European journal of gastroenterology & hepatology\| PubMed ID: 35412484	2022
Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expression. iScience\| PubMed ID: 35479407	2022
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis. Alimentary pharmacology & therapeutics\| PubMed ID: 35484689	2022
Real-world endoscopic and histologic outcomes are correlated with ustekinumab exposure in patients with ulcerative colitis. Journal of Crohn's & colitis\| PubMed ID: 35533353	2022
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Lancet (London, England)\| PubMed ID: 35644154	2022
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY ... Lancet (London, England)\| PubMed ID: 35644155	2022